95 filings
6-K
PHXM
PHAXIAM Therapeutics S.A.
21 Feb 24
PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
6:05am
6-K
PHXM
PHAXIAM Therapeutics S.A.
19 Jan 24
PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024
10:04am
6-K
PHXM
PHAXIAM Therapeutics S.A.
16 Nov 23
PHAXIAM Provides Business and Financial Update
7:41am
6-K
PHXM
PHAXIAM Therapeutics S.A.
25 Oct 23
Current report (foreign)
9:21am
6-K
PHXM
PHAXIAM Therapeutics S.A.
11 Oct 23
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
6:53am
6-K
dqpaxlcg
5 Oct 23
PHAXIAM Therapeutics and Vetophage Announce
7:32am
6-K
iq3pdw0
26 Sep 23
I.Certification of the Person Responsible for the Half-year Financial Report
3:01pm
6-K
a286n lrv7wcid
21 Sep 23
Current report (foreign)
8:42am
6-K
58tu qqpnq
18 Sep 23
PHAXIAM Therapeutics announces the completion of its reverse share split
8:16am
6-K
mlyjrb5j ym
15 Sep 23
Current report (foreign)
8:03am
6-K
4ch9 wixow
7 Sep 23
PHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferences
9:33am
6-K
t1s9u
27 Jul 23
PHAXIAM Therapeutics announces a reverse share split of
4:21pm
6-K
isriresj1s0bi714inh
30 Jun 23
Current report (foreign)
11:33am
6-K
1iae x2ml8
28 Jun 23
Current report (foreign)
8:53am
6-K
zp5g wr0ngi
21 Jun 23
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit
6:09am
6-K
m8a k78mu33nlw5
15 Jun 23
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma
7:32am
6-K
htnky2u4 qjj
12 Jun 23
Current report (foreign)
10:33am
6-K
jfhbs6as75tu
6 Jun 23
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes
7:29am
6-K
dxzkpiiytgz0dx8d9y3
26 May 23
Current report (foreign)
7:39am
6-K
f6r7q1
24 May 23
Exemption Document Prepared In Connection with the Merger by Absorption of Pherecydes Pharma by Erytech Pharma
8:25am